Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis

  • Taking Part in OPTIMA
  • OPTIMA Recruiting Sites
  • The OPTIMA Team
  • Contact Us
  • Taking Part in OPTIMA
    • COVID-19 and OPTIMA
    • About treatment for breast cancer
    • About OPTIMA
    • Who can take part?
    • What's involved in taking part?
    • Patient and public engagement (PPI)
    • More information
    • Is my local hospital recruiting?
    • Privacy Statement
  • OPTIMA Sites
    • COVID-19 and OPTIMA
    • Essential dcuments
    • Newsletters
    • Administering OPTIMA
    • Qualitative Recruitment Study
    • Recruiter training and support
    • Publications
    • OPTIMA governance
  • The OPTIMA Team
  • Contact Us

  • Essential Documents
  • Newsletters
  • Administering OPTIMA
  • Qualitative Recruitment Study
  • Recruiter training and support
  • Publications
  • OPTIMA Governance
  • OPTIMA Prelim Results

Publications

Pubmed:

Strategies to Improve Recruitment to a De-escalation Trial: A Mixed-Methods Study of the OPTIMA Prelim Trial in Early Breast Cancer

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer

Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial

Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.

© 2019 OPTIMA

ABS Badge The OPTIMA Study is funded by National Institute for Health Research (NIHR), Programme (project reference 10/34/501). The information contained in this website is for general information about the OPTIMA study and is provided by the University of Warwick Clinical Trials Unit & University College London. The views expressed are those of the author(s) and are not necessarily those of NIHR or the Department of Health and Social Care or representative of the views of the funder, sponsor or other participating organisations. Trial Registration Number ISRCTN42400492